Nylim US LG Ca R&D LD ETF-UiLRNDETF
13F holders, Q1 2025 (March 31)4holders +1
1new positions
0sold out
$32.15avg. 13F price*
At the end of Q1 2025, 4 institutions reported holding Nylim US LG Ca R&D LD ETF-Ui (LRND) in their 13F filings, up 1 from Q4 2024. 1 opened new positions and 0 sold out. The largest holders were New York Life Investment Management LLC ($6.1M), GTS Securities LLC ($559K) and Assetmark, Inc. ($45K).
- Company
- Nylim US LG Ca R&D LD ETF-Ui
- Filed as
- NEW YORK LIFE INVESTMENTS ET (Q1 2025)
- CUSIP
- 45409B263
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $45K |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 1,834 shares bought, net +1,834 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| New York Life Investment Management LLC | 0.06% | No change | 190,000 | $6.1M |
| GTS Securities LLC | 0.02% | Add +2.6% | 17,383 | $559K |
| Assetmark, Inc. | 0.00% | New | 1,387 | $45K |
| UBS Group AG | 0.00% | No change | 62 | $2K |
"% of holder's portfolio" is LRND's weight in each manager's 13F, not the share of Nylim US LG Ca R&D LD ETF-Ui the manager owns.